Yes, NP said that, but I am not sure what it has to do with not having enough money to start new trials, no BLA in the US or England for HIV at the moment, and no income for COVID use of leronlimab on the horizon (yes, we all pray for great results from s/c interim data which might change that).

As for NP claiming that he is rejecting large offers of money, wasn't he also getting "multiple" term sheets a while back that suddenly went MIA?